The deal activity in the global healthcare sector, including pharmaceuticals and medical equipment, has witnessed second consecutive week of growth, according to GlobalData’s deals database.
The number of deals increased by 5.9% during the week ended 5 April 2020, compared to the earlier week.
Go deeper with GlobalData
GlobalData analyst Aurojyoti Bose said: “This marks the second consecutive week of growth in deal activity for the healthcare sector. Amid COVID-19 concerns, the healthcare sector has been showcasing resilience and witnessing growth in deal activity.”
The US saw a decline in deal activity, while China witnessed growth during the week ended 5 April.
Bose continued: “Announcement of venture financing, partnership and merger and acquisitions (M&A) deals increased by 45.8%, 8.6% and 54.5%, respectively, while licensing agreement and private equity deal volume remained at the same level during the week ended 5 April 2020 compared to the previous week. On the other hand, equity offerings deal volume dropped by 32.5%.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
